Ivacaftor is a pharmaceutical raw material used in the manufacturing of medications for cystic fibrosis. It is included in combination products alongside lumacaftor, tezacaftor, and elexacaftor for broader applicability in certain patient populations.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 873054-44-5
2,4-di-tert-Butyl-5-[(4-oxo-1,4-dihydroquinoline-3-carbonyl)amino]phenyl 4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate for synthesis
Ramipril
active pharmaceutical ingredient
Tolmetin glycinamide
anti-inflammatory pharmaceutical active ingredient
5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-N-[[4-(trifluoromethyl)phenyl]methyl]pyridin-2-amine
dual FMS and KIT kinase inhibitor
BMS-599626 Hydrochloride
active pharmaceutical ingredient
Deutivacaftor
Cystic fibrosis transmembrane conductance regulator potentiator
N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
PURKAOJPTOLRMP-UHFFFAOYSA-N
CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C